Avion Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Avion Wealth's BMY Position: Q2 2026 in Review
Avion Wealth increased its Bristol-Myers Squibb (BMY) stake by 3% in Q2 2026, buying an estimated $574 and bringing the position to 339 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #398.
Avion Wealth first reported a position in BMY in Q3 2019 and has held it in 28 quarters since. The position peaked at $391K in Q2 2022. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Avion Wealth held 339 shares of Bristol-Myers Squibb worth $19K as of Q2 2026.
- Avion Wealth bought 10 Bristol-Myers Squibb shares in Q2 2026, an estimated $574.
- Bristol-Myers Squibb made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #398 holding.
- Avion Wealth first reported a position in Bristol-Myers Squibb in Q3 2019 and has held it in 28 quarters since.
- Avion Wealth's Bristol-Myers Squibb position peaked at $391K in Q2 2022.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.